Temporal association between COVID-19 vaccination and Raynaud’s phenomenon: A case series

References

• World Health Organization. WHO coronavirus (COVID-19) dashboard. [accessed 2023 Mar 15]. https://covid19.who.int/.
   Google Scholar
• Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, Giattino C, Rodés-Guirao L. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947–5. doi:10.1038/s41562-021-01122-8.
   PubMed Web of Science ®Google Scholar
• Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202–21. doi:10.1016/j.cmi.2021.10.005.
   PubMed Web of Science ®Google Scholar
• Urban N, Weber B, Deinsberger J, Gschwandtner M, Bauer W, Handisurya A. Raynaud’s phenomenon after COVID-19 vaccination: causative association, temporal connection, or mere bystander? Case Rep Dermatol. 2021;13(3):450–6. doi:10.1159/000519147.
   PubMed Web of Science ®Google Scholar
• Herrick AL, Wigley FM. Raynaud’s phenomenon. Best Pract Res Clin Rheumatol. 2020;34(1):101474. doi:10.1016/j.berh.2019.101474.
   PubMed Web of Science ®Google Scholar
• Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, Visona A, Heiss C, Brodeman M, Pécsvárady Z, et al. ESVM guidelines – the diagnosis and management of Raynaud’s phenomenon. Vasa. 2017;46(6):413–23. doi:10.1024/0301-1526/a000661.
   PubMed Web of Science ®Google Scholar
• Freeman EE, Sun Q, McMahon DE, Singh R, Fathy R, Tyagi A, Blumenthal K, Hruza GJ, French LE, Fox LP. Skin reactions to COVID-19 vaccines: an American Academy of Dermatology/International League of Dermatological Societies Registry update on reaction location and COVID vaccine type. J Am Acad Dermatol. 2022;86(4):e165–7. doi:10.1016/j.jaad.2021.11.016.
   PubMed Web of Science ®Google Scholar
• Pham-Viet T, Thai-Phuong P, Bui-Viet T, Nguyen-Thi-Ngoc A, Tran-Quoc H, Tran-Phuc L, Duong-Quy S. Subacute Raynaud's syndrome associated with a rare adverse drug reaction of Vaxzevia - AstraZeneca COVID‐19 vaccine: a case report. J Func Vent Pulm. 2021;37(12):1–84. doi:10.12699/jfvpulm.12.37.2021.80.
   Google Scholar
• Tomljenovic L, Colafrancesco S, Perricone C, Shoenfeld Y. Postural orthostatic tachycardia with chronic fatigue after HPV vaccination as part of the “Autoimmune/auto-inflammatory syndrome induced by adjuvants”: case report and literature review. J Investig Med High Impact Case Rep. 2014;2(1):2324709614527812. doi:10.1177/2324709614527812.
   Google Scholar
• Bouquet É, Urbanski G, Lavigne C, Lainé-Cessac P. Unexpected drug-induced Raynaud phenomenon: analysis from the French national pharmacovigilance database. Therapie. 2017;72(5):547–54. doi:10.1016/j.therap.2017.01.008.
   PubMed Web of Science ®Google Scholar
• Hviid A, Svanström H, Scheller NM, Grönlund O, Pasternak B, Arnheim-Dahlström L. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. J Intern Med. 2018;283(2):154–65. doi:10.1111/joim.12694.
   PubMed Web of Science ®Google Scholar
• Selvaraj V, Ogunneye O, Lagu T, Ryzewicz S. A rare case of Raynaud’s vasculitis secondary to hepatitis B vaccination: the induced auto-immune attack syndrome. Case Rep Int Med. 2014;1(1):17–20. doi:10.5430/crim.v1n1p17.
   Google Scholar
• Aksay A, Düzgöl M, Bayram N, Devrim I. A Raynaud phenomonic attack induced after an adult diphtheria-tetanus vaccine. Haydarpasa Numune Med J. 2019;59(3):296–8. doi:10.14744/hnhj.2018.04274.
   Google Scholar
• Ogata AF, Cheng CA, Desjardins M, Senussi Y, Sherman AC, Powell M, Novack L, Von S, Li X, Baden LR, et al. Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients. Clin Infect Dis. 2022;74(4):715–8. doi:10.1093/cid/ciab465.
   PubMed Web of Science ®Google Scholar
• Magro C, Crowson AN, Franks L, Schaffer PR, Whelan P, Nuovo G. The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin. Clin Dermatol. 2021;39(6):966–84. doi:10.1016/j.clindermatol.2021.07.011.
   PubMed Web of Science ®Google Scholar
• Trougakos IP, Terpos E, Alexopoulos H, Politou M, Paraskevis D, Scorilas A, Kastritis E, Andreakos E, Dimopoulos MA. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends Mol Med. 2022;28(7):542–54. doi:10.1016/j.molmed.2022.04.007.
   PubMed Web of Science ®Google Scholar
• Ostrowski SR, Søgaard OS, Tolstrup M, Stærke NB, Lundgren J, Østergaard L, Hvas AM. Inflammation and platelet activation after COVID-19 vaccines - possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis. Front Immunol. 2021;12:779453. doi:10.3389/fimmu.2021.779453.
   PubMed Web of Science ®Google Scholar
• Lei Y, Zhang J, Schiavon CR, He M, Chen L, Shen H, Zhang Y, Yin Q, Cho Y, Andrade L, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128(9):1323–6. doi:10.1161/CIRCRESAHA.121.318902.
   PubMed Web of Science ®Google Scholar
• Terentes-Printzios D, Gardikioti V, Solomou E, Emmanouil E, Gourgouli I, Xydis P, Christopoulou G, Georgakopoulos C, Dima I, Miliou A, et al. The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness. Hypertens Res. 2022;45(5):846–55. doi:10.1038/s41440-022-00876-6.
   PubMed Web of Science ®Google Scholar
• de Laat B, Stragier H, de Laat-Kremers R, Ninivaggi M, Mesotten D, Thiessen S, Van Pelt K, Roest M, Penders J, Vanelderen P, et al. Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S. Front Cardiovasc Med. 2022;9:966028. doi:10.3389/fcvm.2022.966028.
   PubMed Web of Science ®Google Scholar
• Angeli F, Reboldi G, Trapasso M, Zappa M, Spanevello A, Verdecchia P. COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the “spike effect”. Eur J Intern Med. 2022;103:23–8. doi:10.1016/j.ejim.2022.06.015.
   PubMed Web of Science ®Google Scholar
• Nunez-Castilla J, Stebliankin V, Baral P, Balbin CA, Sobhan M, Cickovski T, Mondal AM, Narasimhan G, Chapagain P, Mathee K, et al. Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins. Viruses. 2022;14(7):1415. doi:10.3390/v14071415.
   PubMed Web of Science ®Google Scholar
• Garner R, Kumari R, Lanyon P, Doherty M, Zhang W. Prevalence, risk factors and associations of primary Raynaud’s phenomenon: systematic review and meta-analysis of observational studies. BMJ Open. 2015;5(3):e006389. doi:10.1136/bmjopen-2014-006389.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes Moderna, Pfizer-bioNTech bivalent COVID-19 vaccines for use as a booster dose. [accessed 2023 Feb 8]. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use.
   Google Scholar